CMS Should Fully Automate ASP Data Submissions, OIG Says
This article was originally published in The Pink Sheet Daily
Manufacturers’ submissions of average sales price data from drugs are entered manually by CMS staff; the HHS Inspector General recommends a fully automated process like the one used for average manufacturer price submissions.
You may also be interested in...
CMS 'concurs' with GAO’s recommendation on ASP reports but it’s unclear how much more aggressively it will pursue underlying documentation.
Limitations and irregularities in sales data prevent an accurate comparison of average sales price and widely available market price for Medicare Part B drugs, a differential that can be the basis for modifying reimbursement.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.